The Galien Foundation Announces 2023 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
-- Award Candidates and Winners to be Presented on October 26, 2023, at the Prix Galien USA Forum in New York City
NEW YORK, July 27, 2023 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2023 Prix Galien USA Award nominees for "Best Digital Health Solution," "Best Medical Technology," and "Incubators, Accelerators and Equity." In partnership with Business France, nominees have also been announced for "Best Startup." Winners will be announced during the Prix Galien USA Forum on October 26, 2023, at the Alexandria Center for Life Science in New York City. Nominees in the "Best Medical Technology" category will be previewed during the Prix Galien USA Forum and, later that evening, category winners will be announced during the Prix Galien USA Awards Ceremony at the American Museum of Natural History in New York City.
"The Prix Galien Awards Committee is delighted to celebrate this remarkable group of candidates and selecting this year's winners will be no easy feat," saidBernard Poussot, Director, Roche Holding, Former Chairman & CEO, Wyeth, Prix Galien Medical Technology, Startup, Digital Health and Incubators, Accelerators and Equity Committee Chairman. "This great list of nominees reflects the undeniable courage, dedication, and passion behind each researcher continually working to deliver answers to patients around the world. We applaud their efforts and look forward to celebrating our shared goal of improving the human condition".
In its second year as a Prix Galien Award category, "Incubators, Accelerators and Equity," acknowledges the role played by these institutions in guiding the next wave of innovators by offering a range of mentoring skills, including clinical trial design expertise, legal counsel, lab space, professional development, peer-to-peer support, free access to leading advisors, and economic support to advance life science innovation.
"I'm honored to be returning as an Awards juror as we commend the unwavering commitment of each winner and award nominee in their perseverance of the advancement of global science, healthcare, and wellness," said Alex Gorsky, Former CEO and Executive Chairman, Johnson & Johnson, member of the Prix Galien Startup, Digital Health and Incubators, Accelerators and Equity Committee. "The outstanding quality of the submissions is a testament to the promising future of the life sciences industries."
"It is an honor to serve again on the Prix Galien USA's Awards Committee to advance the mission of The Galien Foundation," said Joel S. Marcus, J.D., CPA, Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments. "This year's winners will represent transformational innovations in life science that have the potential to profoundly impact human health. We celebrate their enduring commitment to improving the lives of patients around the world."
The 2023 Prix Galien USA Medical Technology, Digital Health, Incubators, Accelerators and Equity, and Startup Awards Committee is composed of nine renowned leaders from the biomedical industry and academia, responsible for evaluating nominees. The 2023 Prix Galien Sub-Committees and Advisory Boards conduct a pre-screening of all applications before submitting the shortlist of award candidates to the Awards Committee.
Prix Galien Medical Technology, Digital Health, Incubators, Accelerators and Equity, and Startup Awards Committee 2023
Director, Roche Holding, Former Chairman & CEO, Wyeth
Honorary CEO, UCB
Global R&D President, Pfizer
Former CEO & Executive Chairman, Johnson & Johnson
Global Therapeutic Area Head, Vaccines, Janssen
Board of Directors, AstraZeneca, Former CEO, Avon
Senior Managing Director, Evercore Partners
Joel S. MARCUS
Executive Chairman & Founder, Alexandria
Former Head of Global R&D, Sanofi
Prix Galien Medical Technology Sub-Committee 2023
Executive Vice President, Medical Devices, Abbott
Robert S. LANGER
David H. Koch Institute Professor, Massachusetts Institute of Technology
Cato T. LAURENCIN
M.D., Ph.D., University Professor, University of Connecticut
M.D., Chief Medical Officer, Mayo Clinic-ASU MedTech Accelerator
Head of Innovation Unit– Board of Managing Directors, Boehringer Ingelheim
Prix Galien Incubators, Accelerators, and Equity Category Sub Committee 2023
Managing Partner, Chair Global Health and Purpose, FINN Partners
M.D., Founder, President & CEO, Acorda Therapeutics
Former CEO, Emergent Medical Associates
M.D., Chairman & Chief Curator CNS Summit/Co-Chair Decentralized Trial Research Alliance
M.D., Co-Founder & CEO, Medable Inc.
M.D., Executive Vice President of Health & Wellness, Walmart
J.D., MBA, Advisory Partner – Life Sciences, Molecular Diagnostics, Global Healthcare, PwC Consulting
Prix Galien Startup Advisory Board 2023
Ph.D., Partner, AI and Digital Innovation Fun, Mass General Brigham
Executive Director, Global Strategic Partnerships, Northwell Health
Ph.D., Managing Director, Vertex Venture HC
Managing Partner, Dana Farber Cancer Institute Venture Fund
Ph.D.,Sr. Research Director & Technical Fellow, Medtronic
Founder and Managing Partner at T.Rx Capital
Managing Director, Samsung Next
Corporate SVP, Global Head of Business Development &Licensing (BD&L), Boehringer Ingelheim
Ass. Vice Chancellor, Technology Development Group, UCLA
MS, Life Sciences Investor, Novo Holding
Ph.D., Emerging Science & Innovation, Partnering Pfizer
Founder, Aisling Capital
Ph.D., Partner, MPM Capital
Prix Galien Digital Health Advisory Board 2023
Chief Medical Scientist, Microsoft Research, Microsoft
Executive Vice President, Enterprises Services, Northwell Health
Head, Industry, Healthcare, Google
M.D., Clinical Leader, Healthcare, Amazon
Ph.D., Managing Partner, Rizk Management Advisors, Adjunct Professor, Stevens Institute of Technology
Chief Executive Officer, uMotif
Former Advisor of Sanofi CEO, Healthcare Consultant
About the Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives.
The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa. The Prix Galien was created in 1970 by Roland Mehl in honor of Galien, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
About Business France
Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France. It promotes France's companies, business image and nationwide attractiveness as an investment location, and also runs the VIE international internship program. For further information, please visit: www.businessfrance.fr - @businessfrance
For more information, visit www.galienfoundation.org.
Follow the Foundation on social media:
SOURCE The Galien Foundation